What happened to ASXC stock?
Mar 01, 2022 · Asensus Surgical (ASXC) delivered earnings and revenue surprises of 0% and 7.65%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
Why should you buy asensus Surgical Inc (ASXC) stock?
Find the latest Asensus Surgical, Inc. (ASXC) stock discussion in Yahoo Finance's forum. Share your opinion and gain insight from other stock traders and investors.
Why are sales essential to the success of ASXC?
Apr 20, 2022 · Asensus Surgical Inc. NYSE Updated Apr 20, 2022 4:15 PM ASXC 0.53 0.01 (2.10%). 51,601
What is the predicted opening price for ASXC?
Apr 04, 2021 · And, of course, Reddit isn’t going to support the current price. It didn’t support $6-plus, or $5, or $4. Maybe ASXC stock doesn’t fall all the way back to …
Is ASXC a good investment?
The financial health and growth prospects of ASXC, demonstrate its potential to underperform the market. It currently has a Growth Score of C. Recent price changes and earnings estimate revisions indicate this stock lacks momentum and would be a lackluster choice for momentum investors.
Is ASXC a buy or sell?
The consensus among 1 Wall Street analyst covering (NYSEMKT: ASXC) stock is to Buy ASXC stock.
Why is ascensus surgical dropping?
Asensus Surgical's addition to the Russell 2000 and Russell Microcap Indexes caused a spike in the company's stock price thanks to institutional investor action. After the initial period of increased visibility and demand, the share price has dropped 32% from its high in June.Jul 16, 2021
What happened to Asensus Surgical Inc?
On Feb. 23, the company announced that it was changing its name and ticker symbol. TransEnterix changed its official name to Asensus Surgical on its website and other such official communications. Additionally, on March 5, Asensus' ticker symbol changed from TRXC stock to ASXC stock.Mar 10, 2021
Will ASXC go up?
HC Wainwright & Co. is very positive about ASXC and gave it a "" rating on May 26, 2021. The price target was set to 2.49+22.66....Predicted Opening Price for Asensus Surgical, Inc. of Monday, April 18, 2022.Fair opening price April 18, 2022Current price$0.53$0.53 (Undervalued)
Who owns ASXC stock?
Top 10 Owners of Asensus Surgical IncStockholderStakeTotal changeBlackRock Fund Advisors6.15%+0.89%SSgA Funds Management, Inc.5.37%+7.13%The Vanguard Group, Inc.4.59%+0.72%First Trust Advisors LP1.85%+72.94%6 more rows
What does ascensus surgical do?
Asensus Surgical Inc (NYSE American:ASXC) Asensus Surgical, Inc. is a medical device company, which digitizes the interface between the surgeon and the patient to improve minimally invasive surgery through digital laparoscopy.
Why did TransEnterix change its name?
Research Triangle Park, N.C.-based Asensus Surgical said in a news release that its name change represents its broader vision of shaping the future of surgery by integrating computer vision and machine learning with surgical robotics.Feb 23, 2021
How much did the company lose in 2019?
When did Transenterix change its name?
That quickly fizzled out, however, and 2019 revenues dropped 65% back to just $9 million. For full-year 2019, the company lost $92 million in the course of generating that $9 million of revenue.
How much revenue did the Xfinity brand make in 2019?
On Feb. 23, the company announced that it was changing its name and ticker symbol. TransEnterix changed its official name to Asensus Surgical on its website and other such official communications. Additionally, on March 5, Asensus’ ticker symbol changed from TRXC stock to ASXC stock.
How much stock has Asensus sold in 2021?
The company gained a bit of traction in 2018, with revenues hitting $24 million. That quickly fizzled out, however, and 2019 revenues dropped 65% back to just $9 million.
How much cash did Asensus burn in 2020?
Like AMC and a few others, Asensus has been more aggressive. It’s sold $110 million worth of stock already in 2021. That’s a huge figure. To put it in context, Asensus at the end of 2020 had a market capitalization hovering around $50 million.
How many upgrades will Asensus have in 2020?
More importantly, the capital raises significantly de-risk the story here, at least in the near term. In 2020, Asensus burned $46.7 million in cash. It finished the year with only $16.4 million in unrestricted cash in the bank.
Is Asensus a growing company?
According to the 10-K, Asensus installed 10 Enhance systems in 2020. According to the fourth-quarter earnings release, it expects 10 to 12 installations this year. Yes, Asensus has raised cash. But, again, only enough to get through the end of next year.
Is ASXC stock up in 2021?
While some bulls seem to believe that Asensus is a young, growing company, that’s not the case. It’s been around since 2006. Senhance is the company’s third robotic surgery product. Development of the company’s SPIDER Surgical System was ended all the way back in 2014.
Signals & Forecast
Even down by half from February highs, ASXC stock has gained more nearly 200% so far in 2021. The developer of robotic surgery tools has done little, if anything, to merit that rally. Instead, Asensus (which until a few weeks ago was known as TransEnterix) caught the attention of Redditors.
Support, Risk & Stop-loss
There are few to no technical positive signals at the moment. The Asensus Surgical, Inc. stock holds sell signals from both short and long-term moving averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average.
Is Asensus Surgical, Inc. stock A Buy?
There is no support from accumulated volume below today's level and given the right condition the stock may perform very badly in the next couple of days.
Insiders are neutral as most recent trades are sells in Asensus Surgical, Inc
Asensus Surgical, Inc. holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.
Golden Star Signal
In the last 100 trades there were 5.62 million shares bought and 3.6 million shares sold. The last trade was done 18 days ago by Fernando Anthony C. J. who sold 295.9 thousand shares. For the period there has been more stocks bought than sold among the insiders, but most of the latest transaction have been insiders selling.
Top Fintech Company
This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star. This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!
Name and Ticker Change
A Long Track Record of Failure
- Rather, I’d suggest the company’s management wants folks to forget about the past decade. Over the past decade, on a split-adjusted basis, TRXC aka ASXC stock has plummeted from $100 to just $4 now. That’s a tremendous loss of value, especially during a raging bull market. Additionally, the firm has generated minimal revenues for the past decade. I...
ASXC Stock Verdict
- If you owned TRXC stock for more than a few months, you know this company has a long and underwhelming track record. In general, you should be wary of companies that reverse split their stocks, change their names and ticker symbols, and fail to produce meaningful revenues or profits for many years at a time. As of now, there’s little reason to believe that Asensus Surgical will far…